well, we already know from Prof Kausik Ray's tweet that RVX went back to the FDA with the REQUESTED CHANGES (that was as of 31 May).  RVX then had the meeting on June 02...it went well...maybe the FDA is mulling over a request for shorter and fewer, as you suggest.  Seems like a reasonable request that most companies would make to keep costs lower...we'll see, we'll get there, one way or another